iX Biopharma Ltd announced the allotment and issuance of 47,353 new ordinary shares on Nov, 19 2025, following the exercise of warrants at 0.06 Singapore dollars per share.

As a result, the company’s total issued share capital rose to 955,980,766 shares from 955,933,413 shares.

The newly issued shares will rank pari passu with existing shares and are expected to commence trading on the Singapore Exchange on Nov, 21 2025.

After this transaction, 56,488,158 warrants remain outstanding, each exercisable at 0.06 Singapore dollars and expiring on Jul, 18 2026.